Approach to the patient with a drug hypersensitivity reaction-Clinical perspectives

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 352-365

  Bircher Dr , Andreas J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952867867     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104212     Document Type: Chapter

References (59)

1. Demoly P, Hillaire-Buys D: Classifica-tion and epidemiology of hypersensi-tivity drug reactions. Immunol Allergy Clin North Am 2004; 24: 345-356, v.
2. Bircher AJ: Symptoms and danger signs in acute drug hypersensitivity. Toxicol-ogy 2005; 209: 201-207.
3. Pichler WJ: Adverse side-effects to bio-logical agents. Allergy 2006; 61: 912-920.
4. Barbaud A: Place of excipients in drug-related allergy. Clin Rev Allergy 1995; 13: 253-263.
5. Bigliardi PL, Izakovic J, Weber JM, et al: Anaphylaxis to the carbohydrate carboxymethylcellulose in parenteral corticosteroid preparations. Dermatol-ogy 2003; 207: 100-103.
6. De Smet PAGM: Health risks of herbal remedies. Drug Saf 1995; 13: 81-93.
7. Bircher AJ, Hauri U, Niederer M, et al: Stealth triamcinolone acetonide in a phytocosmetic cream. Br J Dermatol 2002; 146: 531-532.
8. Bircher AJ, Surber C: Unregulated al-ternative medicine. J Drugs Dermatol 2003; 2: 58-61.
9. Nigen S, Knowles SR, Shear NH: Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003; 2: 278-299.
10. Roujeau JC: Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-129.
11. Bircher AJ: Arzneimittelallergie und Haut. Stuttgart, Thieme, 1996.
12. Demoly P, Kropf R, Bircher A, et al: Drug hypersensitivity: questionnaire. Allergy 1999; 54: 999-1003.
13. Lerch M, Pichler WJ: The immunologi-cal and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004; 4: 411-419.
14. Pichler WJ: Direct T-cell stimulations by drugs-bypassing the innate im-mune system. Toxicology 2005; 209: 95-100.
15. Bach S, Bircher AJ: Drug hypersensitiv-ity reactions: from clinical manifesta-tions to an allergologic diagnosis. Al-lerg Immunol (Paris) 2005; 37: 213-218.
16. Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symp-toms: DRESS). Semin Cutan Med Surg 1996; 15: 250-257.
17. Ghislain PD, Roujeau JC: Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Der-matol Online J 2002; 8: 5.
18. Roujeau JC: Treatment of severe drug eruptions. J Dermatol 1999; 26: 718-722.
19. Bircher AJ: Arzneimittelallergie; in Schultze-Werninghaus G, Fuchs T, Bachert C, Wahn U (eds): Manuale al-lergologicum. München-Deisenhofen, Dustri-Verlag, 2004, pp 677-714.
20. Tas E, Pletscher M, Bircher AJ: IgE-mediated urticaria from formaldehyde in a dental root canal compound. J In-vest Allergol Clin Immunol 2002; 12: 130-133.
21. Romano A, Blanca M, Torres MJ, et al: Diagnosis of nonimmediate reactions to β -lactam antibiotics. Allergy 2004; 59: 1153-1160.
22. Torres MJ, Blanca M, Fernandez J, et al: Diagnosis of immediate allergic reac-tions to β-lactam antibiotics. Allergy 2003; 58: 961-972.
23. Aberer W, Bircher A, Romano A, et al: Drug provocation testing in the diag-nosis of drug hypersensitivity reac-tions: general considerations. Allergy 2003; 58: 854-863.
24. Johnson DH, Cunha BA: Drug fever. Infect Dis Clin North Am 1996; 10: 85-91.
25. Quiceno GA, Cush JJ: Iatrogenic rheu-matic syndromes in the elderly. Clin Geriatr Med 2005; 21: 577-588, vii.
26. Schlienger R, Bircher AJ, Meier CR: Minocycline-induced lupus. Dermatol-ogy 2000; 200: 223-231.
27. Wiik A: Clinical and laboratory charac-teristics of drug-induced vasculitic syndromes. Arthritis Res Ther 2005; 7: 191-192.
28. Spanou Z, Keller M, Britschgi M, et al: Involvement of drug-specific T cells in acute drug-induced interstitial nephri-tis. J Am Soc Nephrol 2006; 17: 2919-2927.
29. Bircher AJ: Drug-induced urticaria and angioedema. Eur J Dermatol 1999; 9: 657-663.
30. Wolf R, Orion E, Marcos B, et al: Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005; 23: 171-181.
31. Prussick R, Knowles S, Shear NH: Cu-taneous drug reactions. Curr Probl Dermatol 1994; 6: 85-122.
32. Wolkenstein P, Revuz J: Drug-induced severe skin reactions. Incidence, man-agement and prevention. Drug Safety 1995; 13: 56-68.
33. Descamps V, Bouscarat F, Laglenne S, et al: Human herpesvirus 6 infection associated with anticonvulsant hyper-sensitivity syndrome and reactive hae-mophagocytic syndrome. Br J Dermatol 1997; 137: 605-608.
34. Descamps V, Valance A, Edlinger C, et al: Association of human herpesvirus 6 infection with drug reaction with eo-sinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304.
35. Kano Y, Hiraharas K, Sakuma K, et al: Several herpesviruses can reactivate in a severe drug-induced multiorgan reac-tion in the same sequential order as in graft-versus-host disease. Br J Derma-tol 2006; 155: 301-306.
36. Seishima M, Yamanaka S, Fujisawa T, et al: Reactivation of human herpesvi-rus (HHV) family members other than HHV-6 in drug-induced hypersensitiv-ity syndrome. Br J Dermatol 2006; 155: 344-349.
37. Scherer K, Bircher AJ: Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005; 5: 15-21.
38. Hyson C, Sadler M: Cross-sensitivity of skin rashes with antiepileptic drugs. Can J Neurol Sci 1997; 24: 245-249.
39. Brockow K, Christiansen C, Kanny G, et al: Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60: 150-158.
40. Kanny G, Pichler W, Morisset M, et al: T-cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005; 115: 179-185.
41. Van Renterghem D, De Vries EA: Pseu-do-lymphoma and anticonvulsant hy-persensitivity syndrome during the use of anti-epileptic agents. Tijdschr Ge-neeskd 1997; 53: 399-403.
42. Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symp-toms: DRESS). Semin Cut Med Surg 1996; 15: 250-257.
43. Roujeau JC, Bioulac-Sage P, Bourseau C, et al: Acute generalized exanthema-tous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127: 1333-1338.
44. Häusermann P, Scherer K, Weber M, et al: Ciprofloxacin-induced acute gener-alized exanthematous pustulosis mim-icking bullous drug eruption confirmed by a positive patch test. Dermatology 2005; 211: 277-280.
45. Sidoroff A, Halevy S, Bavinck JN, et al: Acute generalized exanthematous pus-tulosis-a clinical reaction pattern. J Cutan Pathol 2001; 28: 113-119.
46. Häusermann P, Harr T, Bircher AJ: Ba-boon syndrome resulting from system-ic drugs: is there strife between SDRIFE and allergic contact dermatitis syn-drome? Contact Dermatitis 2004; 51: 297-310.
47. Häusermann P, Bircher AJ: SDRIFE-another acronym for a distinct cutane-ous drug exanthema. Do we really need it? Dermatology 2007; 214: 1-2.
48. Lee AY: Fixed drug eruptions. Inci-dence, recognition, and avoidance. Am J Clin Dermatol 2000; 1: 277-285.
49. Shiohara T, Mizukawa Y, Teraki Y: Pathophysiology of fixed drug erup-tion: the role of skin-resident T cells. Curr Opin Allergy Clin Immunol 2002; 2: 317-323.
50. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
51. Auquier-Dunant A, Mockenhaupt M, Naldi L, et al: Correlations between clinical patterns and causes of erythe-ma multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrol-ysis: results of an international pro-spective study. Arch Dermatol 2002; 138: 1019-1024.
52. Doyle MK, Cuellar ML: Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2: 401-409.
53. Navi D, Michael DJ, Fazel N: Drug-in-duced linear IgA bullous dermatosis. Dermatol Online J 2006; 12: 12.
54. Onodera H, Mihm MC Jr, Yoshida A, et al: Drug-induced linear IgA bullous dermatosis. J Dermatol 2005; 32: 759-764.
55. Brockow K, Romano A, Blanca M, et al: General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
56. Romano A, Di Fonso M, Papa G, et al: Evaluation of adverse cutaneous reac-tions to aminopenicillins with empha-sis on those manifested by maculopap-ular rashes. Allergy 1995; 50: 113-118.
57. De Weck AL, Sanz ML: Cellular aller-gen stimulation test (CAST) 2003, a review. J Investig Allergol Clin Immu-nol 2004; 14: 253-273.
58. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-820.
59. Arnold AW, Häusermann P, Bach S, et al: Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two iodinated con-trast media. Dermatology 2007; 214: 89-93.